Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 8

1.

Lethal multiple sclerosis relapse after natalizumab withdrawal.

Rigau V, Mania A, Béfort P, Carlander B, Jonquet O, Lassmann H, Camu W, Thouvenot E.

Neurology. 2012 Nov 27;79(22):2214-6. doi: 10.1212/WNL.0b013e318275979d. Epub 2012 Oct 24. No abstract available.

PMID:
23100404
2.

Natalizumab for relapsing-remitting multiple sclerosis.

Horga A, Tintoré M.

Neurologia. 2011 Jul-Aug;26(6):357-68. doi: 10.1016/j.nrl.2010.10.004. Epub 2010 Dec 28. Review. English, Spanish.

3.

Progressive multifocal leukoencephalopathy and natalizumab.

Hellwig K, Gold R.

J Neurol. 2011 Nov;258(11):1920-8. doi: 10.1007/s00415-011-6116-8. Epub 2011 Jun 7. Review.

PMID:
21647730
4.

Natalizumab: state of the art and open questions.

Comi G.

Neurol Sci. 2011 Jan;31 Suppl 3:313-5. doi: 10.1007/s10072-010-0430-2. Review. No abstract available.

PMID:
21107875
5.

[2012: Update on diagnosis and treatment of multiple sclerosis].

Havla J, Kümpfel T, Hohlfeld R.

Dtsch Med Wochenschr. 2012 Apr;137(17):894-9. doi: 10.1055/s-0032-1304927. Epub 2012 Apr 10. Review. German. No abstract available. Erratum in: Dtsch Med Wochenschr. 2012 May;137(20):1072.

PMID:
22492476
6.

Multiple sclerosis, natalizumab therapy, and progressive multifocal leukoencephalopathy.

Bartt RE.

Curr Opin Neurol. 2006 Aug;19(4):341-9. Review.

PMID:
16914971
7.

Natalizumab (Tysabri) treatment for relapsing multiple sclerosis.

Johnson KP.

Neurologist. 2007 Jul;13(4):182-7. Review.

PMID:
17622909
8.

Improvement of visual acuity in patients with severe visual loss affected by multiple sclerosis treated with natalizumab: a case report.

Florio C, Maniscalco GT.

Neurol Sci. 2011 Jan;31 Suppl 3:325-7. doi: 10.1007/s10072-010-0349-7. Review.

PMID:
20596742

Supplemental Content

Support Center